Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the first quarter of fiscal 2024 ended December 31, 2023. “We’re starting fiscal 2024 off strong…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks